chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose on 2019, had not received second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 20th November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive second dose, which led to incomplete course of vaccination. The reporter consented to follow up. This case is linked with the case US2021238459 and US2021238463, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021238459:same reporter US-GLAXOSMITHKLINE-US2021238463:Same reporter
Infection; Missed my second dose because he was taking antibiotics; A spontaneous report was received from a consumer concerning himself, a male patient who experienced an infection causing him to miss his second dose of mRNA-1273 because he was taking antibiotics (product dose omission issue).  The patient's medical history was not provided. Concomitant product use was not provided/unknown.   On an unknown date, this patient received his first of two planned doses of mRNA-1273 (Lot/Batch number: Not provided) intramuscularly for prophylaxis of COVID-19 infection.   On 15-Mar-2021, the patient was scheduled for his second dose of the vaccine, but missed this dose because he was on antibiotics for an infection.  Treatment information was not provided/unknown.  Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome for the events, infection and missed second dose because he was taking antibiotics, were not provided/unknown.
Fever of 103 for 72 hours. Rash (all over body) began 6/24/11 for 48 hours. He was crying inconsolably for much of the time he had the fever. Obviously very uncomfortable. He did not want to walk or crawl during this time.
It kicked my butt; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included ophthalmic herpes zoster (started from 5th January 2022).   On 19th July 2022, the patient received the 2nd dose of Shingrix. In July 2022, less than a week after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.     Additional Information: GSK receipt date: 23-JUL-2022 Reporter's comments: This case was reported by consumer via interactive digital media. The patient had shingles on face starting from 5th January 2022 that went into right eye.  The patient had 10 visits to eye doctor and patient's vision was still not 100 percent as the time of reporting.  Got second dose of Shingrix this past Tuesday (from date of reporting) and it was reported that it kicked patient's butt as bad as it was. The patient could not take a chance on facial shingles again. The follow up would not be possible as contact details were not provided.
Anaphalaxis occurred within minutes of the injection.  Expired epipen was used which alleviated the immediate symptoms, but it persisted in a mild form for 3 days.  Upon returning home, I was seen in office by my Immunologist, Dr., who administered a prednisone injection, which alleviated the symptoms.   Followed up with testing provided by CDC.  More detail is possible, but this form does not work properly and won't allow me to continue to additional information.  Ironic.
Myalgia fatigue Narrative: severe muscle pain 1/20/2021, mild muscle pain 1/22/2021, moderate fatigue x2 days, resulted in unable to work 2 days.
Inappropriate Reconstitution Technique; Inappropriate dose of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13-OCT-2023, the patient received Shingrix. On 13-OCT-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 13-OCT-2023 The health care professional (HCP) unable to provide any patient or vaccine details.  The reporter confirmed the patient was administered the Shingrix AS01b Liquid component without the lyophilized component today (on the day of reporting). HCP mentioned unsure but thought the physician advised to administer a complete dose after diluent only dose. The patient received only diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered The reporter did not consent to follow-up.
Two days after administration of first COVID-19 vaccination, patient developed blood streaked diarrhea and abdominal pain. Patient was referred to emergency room, prescribed Lomotil, workup for IBD. History of poor weight gain, C.diff infection 2 years ago (2019). Patient referred to GI for further work up.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had a sore arm at the injection site after receiving his dose of SHINGRIX vaccine. The call center representative was unable to obtain the physician's name and phone number secondary to call flow.
I am experiencing kidney pain post vaccination.  It is bilateral and rates a 2-3/10.  I am remembering now that I had this after other COVID vaccinations, but memory fails on the details.  I had written it off to other causes but felt today when I made the connection, that I should report it.
Shortness of breath; Swelling of feet; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M204A and 038K204) for COVID-19 vaccination.     Concurrent medical conditions included Chronic obstructive pulmonary disease. Concomitant products included FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA RESPIMAT), MONTELUKAST SODIUM (SINGULAIR), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D), ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN C [ASCORBIC ACID] and VITAMIN E [VITAMIN E NOS] for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet). At the time of the report, DYSPNOEA (Shortness of breath) and PERIPHERAL SWELLING (Swelling of feet) had not resolved.            No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received on 29 Jul 2021, The follow-up document contains No New Information
This is a spontaneous report obtained from a contactable consumer (patient). A 66 year old female patient received, on an unspecified date, in Nov2015, PREVNAR 13 single dose, and flu vaccine, in the arm, both for immunization. Relevant medical history included breast cancer (radiation treatments and ARIMIDEX for 5 years from 2010 to Oct2015), blood cholesterol abnormal, hole in heart, blood pressure. Past drug included ALLEGRA 180 mg 3 times a day. Concomitant medications included oral losartan 50 mg, once daily, for blood pressure; oral fish oil 1600 mg, daily, from an unspecified date to Dec2015, for blood cholesterol abnormal; oral NIACIN) 1500 mg, once daily, from an unspecified date to Dec2015, for blood cholesterol abnormal; and oral ASPIRIN 325 mg, once daily, from an unspecified date to 23May2017, for hole in heart. On an unspecified date, in Nov2015, the patient experienced hives on her legs and it then spread to her whole body and on an unspecified date itching. Treatment was received. The patient did not recover from hives, while clinical outcome of the other event was unknown. Then she went to her endocrinologist and was put on levothyroxine. She was on the levothyroxine for a month; from Apr2016 at 75 mcg dose.
The pt was taken to the ER with deltoid swelling to approximately 8 cm, redness, hardness and pain. Was treated and released. Instructed to apply ice and give Motrin every 4 hours for pain.
Reporting an error. Patient was given his third dose of Moderna of 0.5 ml instead of 0.25ml. Patient tolerated dose well. Did not have any adverse reaction. This is the first of two patients who received this dose.  Stopped Moderna booster after I became aware that it was not yet approved.  Other patient was reported on already.
Red, hard, swelling on L arm. Dr.  recommended ice / ibuprofen.
inability to move arm; lightheadedness; nausea; excruciating pain in arm; This spontaneous case was reported by a patient and describes the occurrence of LIMB DISCOMFORT (inability to move arm), DIZZINESS (lightheadedness), NAUSEA (nausea) and MYALGIA (excruciating pain in arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced LIMB DISCOMFORT (inability to move arm), DIZZINESS (lightheadedness), NAUSEA (nausea) and MYALGIA (excruciating pain in arm). The patient was treated with IBUPROFEN at a dose of 800 mg twice a day. At the time of the report, LIMB DISCOMFORT (inability to move arm), DIZZINESS (lightheadedness), NAUSEA (nausea) and MYALGIA (excruciating pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
Swollen lymph nodes and pain in underarm on the side of the vaccination. Visibly swollen lymph nodes in the armpit.
second dose's being delayed due to her reported symptoms; sore right arm at the injection site; weirdly tired; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose's being delayed due to her reported symptoms), VACCINATION SITE PAIN (sore right arm at the injection site) and FATIGUE (weirdly tired) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore right arm at the injection site) and FATIGUE (weirdly tired). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose's being delayed due to her reported symptoms). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose's being delayed due to her reported symptoms) had resolved, VACCINATION SITE PAIN (sore right arm at the injection site) was resolving and FATIGUE (weirdly tired) outcome was unknown. Not Provided          No treatment medications were provided. No concomitant medications were provided.   This case was linked to MOD-2021-017063 (Patient Link).
chest tightness, tingling in l arm and face Narrative: after 20 minutes developed chest tightness, tingling into left arm and face and face. Medical code called and taken to ER. Given meds and released after improvement.
Monday, four days after vaccination, Awoke feeling "off" and about noon after Physical therapy treatment felt worse, really tired, went home to bed, slept, no appetite; 1:00 PM fever 99.9  about 3:00 PM fever 100.9; general body aches, ate a small supper. Went to bed,  Slept well, awoke  feeling  good.  No more problems.
Patient here for COVID vaccine.  Patient's left deltoid muscle was punctured with needle.  After puncture I noted that the syringe was empty, there was nothing in syringle.   Site Coordinator, was notified and situation was explained to patient.
Missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.   On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication was reported.  It was not reported if the patient was received any corrective treatment for the event.
GARDASIL 9 Lot no. L001312 had seizure like activity only on (L) side lasting 20 sec. No prior reactions noted on any vaccines.
10 days after injection, injection site became hot to touch, itchy and slightly red. Within 1 hour left arm became numb and tingly. Soon after left leg also became numb and tingly. Benadryl and Ibuprofen was taken as directed and symptoms resolved within 24 hours.
7 days after 1st injection (5/14/21) , right arm started itching, was warm to the touch, and had a red welt  approx. 2x2 inches. Each day thereafter, the redness continued to increase in diameter. 5 days after delayed reaction began (5/18/21), the redness/warmth/welt was approx. 7x7 inches. Had virtual appt with my doctor who prescribed triamcinolone cream 0.1% for the itching and inflammation. On day 6 of delayed reaction (5/20/21), there was no additional spread of the redness. Slowly the redness/warmth/welt faded. Today (5/28/21) it is resolved - you can barely see the outline of the redness. No other symptoms.
From the time, and day this vaccine was administered to me I have been in pain shoulder and back/hip.
Post 1st vaccine Left Arm Hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Post 1st vaccine Left Arm Hurt a little) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 013M20A) for COVID-19 vaccination. The patient's past medical history included Fibromyalgia and Irritable bowel syndrome.On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Jan-2021, the patient experienced PAIN IN EXTREMITY (Post 1st vaccine Left Arm Hurt a little). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Jan-2021, PAIN IN EXTREMITY (Post 1st vaccine Left Arm Hurt a little) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.Treatment details also include Ice.
Patient reported she had received last booster August 2022. There were multiple people in the clinic coming and going to get cards, being checked in and asking/answering questions. In the confusion, it was overlooked the the actual date of the last booster was September 2022, and she had already received the bivalent booster. She therefore received a 2nd bivalent.
She got her vaccine, a few days later she started with redness in the white of her eyes, and they are still a little red and still watery.  She also had burning in her body and itching, and not feeling good.  The burning and itching was all over her body.  She did notifiy the doctor and went to see him, and went to the ER a few days after she saw her body as she could not get over the burning and itching and gave her a prescription for itching.  Her PCP did not say much and feels like she had an allergy to it.  She did not give her anything for her symptoms.  She got the itching pills from the ER.  She is still having the burning pain in her body.  She has a slight headache that she doesn't have to take anything for and checked her head for tumors and has an itchy scalp and a tad of a headache and pain in her neck and head.  She did not have these symptoms with the itching problems prior to the vaccine.  She did have a flat rash on her neck and arm, and when the doctor looked on it she was told that it was the start of shingles, but she had had the shingles vaccine a few weeks prior to that.  She was given Valacyclovir 10 mg. 3 times a day.
A few hours after the vaccine on 3/17 , developed itching right lower abdomen/side.  Within 5 hours of receiving vaccine, developed a rash that itches and hurts.  On 3/19 came back to the clinic for evaluation, diagnosed with shingles.  Has a cluster of erythematous vesicles on an erythematous base.  Started on Valacyclovir 1gm every 8 hours x 7 days.
Blurred vision was the only weird one. I had aches and fatigue and arm pain that were normal reactions. I called and reported it to my doctor. No further treatment at this time.
Onset of neck pain, wrist and hand, knee, left foot pain and rash upper chest 24 hours after Hepatitis B immunization.
About 12 hours afterward, I woke up with chest tightness, pain and a heaviness in my chest/heart area. These symptoms persisted to a lesser degree for days afterward but were significant the first night.
Huge bumps (resembles severe acne) all over my forehead. No pain, small amount of pus. Bumps are extremely dark in color, at least 2-3 shades darker than my normal skin complexion.  Deep red itchy rash in the center of my chest. No bumps present just a large red patch. Looks like sunburn and extremely itchy.
Within the first minutes after the vaccine had a taste of metal in my mouth, and has stayed consistently for over 8 hours. Still experiencing now.
No actual adverse event, patient was just underage per manufacturer recommendations. A digit was missed at her initial assment on her birth month making the screener believe she was 18 when she was actual 17. She reported no side effects after either dose other than sore arm.
Patient reported a rapidly expanding swelling at the vaccine site. Day 1 50 cent size. Day 2 apple size. Day 3 grapefruit size, no fever. Reports tenderness and warmth at the site.
24 hour history of discomfort between left nipple and costal margin. radiating to back, worsened with position such as lying flat or leaning forward. Diffuse ST segment elevations V3 to V6 as well as 1, 2 aVF.  ST depression and subtle PR elevation in aVRort between left nipple and costal margin. radiating to back, worsened with position such as lying flat or leaning forward.  27 yr old with abd and chest pain.  ECG only abnormality.  Longer time from 2nd vaccination to chest/abdominal pain so ? etiology idiopathic??
11/07/2022 tested positive for COVID-19. I had chills and a headache. My symptoms were relatively mild so I did not seek medical care. Symptoms lasted 2-3 days. No medications.
Flu like symptoms; the whole room was going around in circles (like he had taken a shot of whiskey); Lot of pain in the shoulders; Fall; Could not lift his body up; Felt like muscle in his legs not working; lightheadedness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness), PAIN IN EXTREMITY (Sore arm), FALL (Fall), MOBILITY DECREASED (Could not lift his body up) and FEELING ABNORMAL (Felt like muscle in his legs not working) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022A20A and 037A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cough (Treated cough with Hycodan but weaned off and used tramadol as needed.) and Neck pain (possibly nerve damage). Concomitant products included TRAZODONE HYDROCHLORIDE (DESYREL), DILTIAZEM HYDROCHLORIDE (CARDIZEM CD), ALPRAZOLAM (XANAX), GABAPENTIN (NEURONTIN), INSULIN GLARGINE (TOUJEO), EMPAGLIFLOZIN (JARDIANCE), QUETIAPINE FUMARATE (SEROQUEL) and CYCLOBENZAPRINE for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (lightheadedness) and PAIN IN EXTREMITY (Sore arm). On 04-Apr-2021, the patient experienced FALL (Fall), MOBILITY DECREASED (Could not lift his body up) and FEELING ABNORMAL (Felt like muscle in his legs not working). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VERTIGO (the whole room was going around in circles (like he had taken a shot of whiskey)) and ARTHRALGIA (Lot of pain in the shoulders). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, DIZZINESS (lightheadedness), PAIN IN EXTREMITY (Sore arm), FALL (Fall), MOBILITY DECREASED (Could not lift his body up), FEELING ABNORMAL (Felt like muscle in his legs not working) and VERTIGO (the whole room was going around in circles (like he had taken a shot of whiskey)) outcome was unknown and INFLUENZA LIKE ILLNESS (Flu like symptoms) and ARTHRALGIA (Lot of pain in the shoulders) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Added patient demographics (medical history) , Added new events (Arthralgia, Vertigo, Influenza like illness) and Added treatment drug Ibuprofen.